5-Jun-2009
CLINIMETRICS EXHIBITS AT 45TH ANNUAL DRUG INFORMATION ASSSOCIATION MEETING IN SAN DIEGO, CA, JUNE 21-25, 2009

More Info...
27-Mar-2009
CLINIMETRICS REINTRODUCES IN-HOUSE STAFFING SERVICES

More Info...
14-Jan-2009
CLINIMETRICS ANNOUNCES RETIREMENT OF FOUNDER AND CEO

More Info...



Clinimetrics manages global development programs and is your partner in research excellence.

Corporate Offices

U.S. Operations

Canadian Operations


US and International Regulatory Affairs

We recognize the importance of timely and accurate Regulatory submissions as well as the need to foster and coordinate a team effort in drug development. Our Regulatory Affairs staff and affiliates have extensive pharmaceutical drug development experience and offer customized regulatory solutions through every phase of product development, review and commercialization.

Regulatory services include:

  • Regulatory consultation
  • Regulatory document preparation and submission
  • Safety Monitoring

Regulatory assistance can be provided for both device and pharmaceutical development, for the FDA or international Regulatory Agencies.

Essential services include:

  • Sponsor representation with FDA or Regulatory around the world
  • Pre-IND submissions and meetings
  • Investigational (IND and IDE) applications in the United States and internationally
  • Regulatory filing packages for clinical studies
  • Submission and review of Institutional Review Board approvals for clinical studies
  • Regulatory Maintenance: Annual Reports, SAE reports
  • Data Safety Monitoring Boards
  • Investigator Brochures and regular updates
  • Product license applications (NDA, BLA, PMA, Common Technical Document) in US and Internationally
  • Multinational and multilingual regulatory affairs group
  • Regulatory expertise covers wide range of therapeutic areas and types of submissions
  • Regulatory consulting services: Global program development, evaluation and risk assessment
  • Innovative approaches to support effective and timely resolution of regulatory issues
  • Proactive liaison and interface with key FDA review and compliance divisions and international regulatory authorities
  • Planning strategies for most effective and timely review and approval of regulatory submissions
  • Investigational products, marketing approvals, drug master files, orphan drugs and priority review submissions
  • Electronic submissions
  • Expert reports for EU product submissions
  • Post-marketing surveillance/pharmacovigilance
  • Development of Standard Operating Procedures
  • Development and maintenance of Regulatory Tracking database



© COPYRIGHT CLINIMETRICS 2009. ALL RIGHTS RESERVED.